LATEST NEWS   All 1,936 Malaysian students in the Middle East are reported safe following the geopolitical conflict in the region - Zambry | PM Anwar conveys condolences on the passing of Indonesia's sixth Vice-President Try Sutrisno | Ringgit closes lower at 3.9225/9295 versus US dollar from 3.8910/8960 last Friday | Velesto Energy's subsidiary secures jack-up drilling rig contract worth US$157 mln for 2026-2030 period from Petronas Carigali | Quran desecration case: Male student to be charged under Section 295 of the Penal Code and Section 233 (1)(a) of Communications and Multimedia Act - AGC | 

KPJ Healthcare Records Improved Net Profit, Revenue In FY2025

KUALA LUMPUR, Feb 26 (Bernama) -- KPJ Healthcare Bhd’s net profit increased to RM365.92 million in the financial year ended Dec 31, 2025 (FY2025) from RM353.81 million a year ago.

Revenue rose to RM4.25 billion against RM3.89 billion a year earlier, largely contributed by a higher number of patients’ visits, a Bursa Malaysia filing said today.

KPJ Healthcare declared a first interim dividend of 1.35 sen per share for FY2026, totalling RM59.2 million, payable April 17, 2026.

It said operational beds increased four per cent year-on-year as capacity expansion progressed, while surgical cases rose 11 per cent and average revenue per inpatient increased seven per cent, reflecting continued growth in patient activity across the network.

KPJ Healthcare said it remains focused on balancing utilisation, clinical quality and cost discipline amid ongoing workforce and cost pressures affecting the healthcare sector.

“FY2025 reflects clear progress in strengthening revenue quality, operating leverage and system integration across the group. Growth, supported by resilient patient demand, improving case mix and deeper specialist capability, is shifting KPJ toward higher-acuity, value-generative services,” KPJ Healthcare president/managing director Chin Keat Chyuan said in a separate statement today. 

He added that the next phase of KPJ Healthcare’s growth would be driven by the convergence of artificial intelligence, genomics and value-based care within a unified operating model.

It remains cautiously optimistic about its 2026 prospects, supported by its ongoing asset optimisation programme, continued capacity expansion and sustained focus on enhancing operational efficiency.

-- BERNAMA